Congestive heart failure, treatment

Congestive heart failure treatment may be improved by cautiously adding a /3-blocker to conventional management with ACE-inhibitors and diuretics. Bisoprolol and carvedilol are the preferable /3-blockers, since their beneficial effect has been convincngly demonstrated in appropriate clinical trials. Bisoprolol is a highly selective /8i-blocker. Carvedilol has additional properties to its /8-receptor blocking activity, such as a weak vasodilator component and anti-oxidant activity. The beneficial effect is very likely to be caused by /8i-adrenoceptor blockade. 

CARDIAC GLYCOSIDES have a pronounced effect on the failing heart, increasing the force of contraction, so they were formerly widely used to Increase the force in congestive heart failure treatment (e.g. digitoxin, digoxin). 

The remainder of the compounds cover a wide range of activities, from parts of human parathyroid hormone through human chorionic gonadotropin (hCG) to the very interesting congestive heart failure treatment with a portion of the human B-type natriuretic peptide, Natrecor . 

Calcium-channel blockers for the treatment of hypertension Calcium products Cephalosporins Cerebroactive medications Chlamydial infections treatment of Cholinergic drugs uses in medicine Cholinergic-receptor-blocking agents uses of Cirrhosis treatment of Congestive heart failure treatment of Constipation drug-induced Corticosteroids uses for Crohn s disease treatment of Cytokines their actions... 

PATHOPHYSIOLOGY OF CONGESTIVE HEART FAILURE TREATMENT STRATEGIES... 

---